Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

366
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
366
Oogenesis02:07

Oogenesis

63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

1.5K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
1.5K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

396
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
396
Infertility in Females01:28

Infertility in Females

309
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
309
Menopause01:28

Menopause

169
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
169

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Copper-Targeted Therapy in Experimental Endometriosis: Effects of Ammonium Tetrathiomolybdate on Markers of the Interconnected Processes of Inflammation, Innervation, and Fibrogenesis.

International journal of molecular sciences·2026
Same author

Daily temporal organization of inflammation and cognition-related factors and antioxidant enzymes are modified by an intracerebroventricular injection of amyloid-beta peptide (1-42) aggregates in the rat temporal cortex.

Brain research·2025
Same author

The gold complex auranofin sensitizes platinum resistant epithelial ovarian cancer cells to cisplatin.

Biochemistry and biophysics reports·2025
Same author

Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression.

Cancers·2024
Same author

Estetrol Inhibits Endometriosis Development in an In Vivo Murine Model.

Biomolecules·2024
Same author

Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells.

Cancers·2023

Related Experiment Video

Updated: Jul 7, 2025

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

1.4K

Copper in Gynecological Diseases.

Rocío A Conforti1, María B Delsouc1, Edith Zorychta2

  • 1Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis (UNSL), Instituto Multidisciplinario de Investigaciones Biológicas de San Luis (IMIBIO-SL-CONICET), San Luis CP D5700HHW, Argentina.

International Journal of Molecular Sciences
|December 23, 2023
PubMed
Summary

Copper (Cu) is vital for cell function but toxic in excess. This study explores copper

Keywords:
Cu chelatorsCu ionophorescervical cancercopperendometrial cancerendometriosisgynecological diseasesovarian cancerpolycystic ovarian syndrome

More Related Videos

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
08:11

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria

Published on: May 16, 2025

121
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.2K

Related Experiment Videos

Last Updated: Jul 7, 2025

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

1.4K
Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
08:11

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria

Published on: May 16, 2025

121
Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
11:04

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

9.2K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Copper (Cu) is an essential micronutrient critical for eukaryotic development, involved in enzymatic activity, oxygen transport, and cell signaling.
  • Copper's redox activity, while vital for enzymes, poses toxicity risks at high concentrations, necessitating strict homeostatic control.
  • Dysregulation of copper homeostasis is linked to various diseases, including neurodegenerative disorders, diabetes, cancer, Menkes', and Wilson's diseases.

Purpose of the Study:

  • To investigate the multifaceted role of copper in fundamental tumor progression processes: cell proliferation, angiogenesis, and metastasis.
  • To analyze the intricate relationship between copper deregulation and gynecological diseases.
  • To explore potential therapeutic strategies targeting copper in gynecological conditions.

Main Methods:

  • Literature review and analysis of existing research on copper's role in cancer and gynecological diseases.
  • Examination of cellular and molecular mechanisms linking copper dysregulation to tumor progression.
  • Synthesis of information on therapeutic interventions involving copper modulation.

Main Results:

  • Copper significantly influences cell proliferation, angiogenesis, and metastasis, key factors in cancer development.
  • Copper dyshomeostasis is implicated in the pathogenesis of gynecological diseases, with shared mechanisms to general cancer progression.
  • Altered copper levels are observed in various gynecological pathologies, suggesting its potential as a biomarker or therapeutic target.

Conclusions:

  • Copper's dual role as essential nutrient and potential toxin highlights its complex involvement in disease.
  • Understanding copper's impact on gynecological diseases offers new avenues for diagnosis and treatment.
  • Targeting copper metabolism presents a promising strategy for novel therapeutic approaches in gynecological oncology.